Keros Therapeutics Inc (KROS)

12:31 PM

Wells Fargo & Company Cuts Keros Therapeutics (NASDAQ:KROS) Price Target to $20.00 - MarketBeat

12:31 PM

12:21 PM

Wells Fargo Maintains "Overweight" on Keros Therapeutics (KROS), Lowers Price Target | KROS Stock News - GuruFocus

12:21 PM

05:55 AM

Keros Therapeutics Reports FY25 Results, Highlights Progress Across Hematology And Muscle Pipeline - Nasdaq

05:55 AM

Mar 04, 2026

Keros Therapeutics, Inc. (KROS) Reports Q4 Loss, Misses Revenue Estimates - Bitget

Mar 04, 2026

Mar 04, 2026

Keros Therapeutics (NASDAQ: KROS) lands $200M Takeda deal and advances TGF-ß pipeline - Stock Titan

Mar 04, 2026

Mar 04, 2026

Keros Therapeutics (NASDAQ: KROS) swings to 2025 profit on Takeda license windfall - Stock Titan

Mar 04, 2026

Mar 04, 2026

Keros Highlights Rinvatercept Strategy in Updated Investor Presentation - TipRanks

Mar 04, 2026

Mar 04, 2026

Keros Therapeutics (NASDAQ:KROS) Posts Earnings Results, Misses Estimates By $0.37 EPS - MarketBeat

Mar 04, 2026

Mar 04, 2026

Biotech behind new DMD and ALS trials turns 2024 loss into 2025 profit - Stock Titan

Mar 04, 2026

Mar 03, 2026

KROS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 03, 2026

Mar 01, 2026

ADAR1 Issues Open Letter to Keros Board, Encouraging Constructive Dialogue on Strategy, Capital Allocation, and Board Renewal - Intellectia AI

Mar 01, 2026

Feb 28, 2026

Keros Therapeutics Touts Rinvat­ercept DMD Trial Start, Eyes ALS Phase II Talks at Oppenheimer Conference - Yahoo Finance

Feb 28, 2026

Feb 28, 2026

Trading the Move, Not the Narrative: (KROS) Edition - Stock Traders Daily

Feb 28, 2026

Feb 27, 2026

Keros Therapeutics, Inc. (KROS) Investor Outlook: Exploring The 53% Potential Upside - DirectorsTalk Interviews

Feb 27, 2026

Feb 27, 2026

Keros Therapeutics, Inc. $KROS is Western Standard LLC's Largest Position - MarketBeat

Feb 27, 2026

Feb 26, 2026

Keros Therapeutics Adds Veteran Finance Leader to Board - TipRanks

Feb 26, 2026

Feb 26, 2026

Keros Therapeutics adds former Lyell CFO to board - Investing.com

Feb 26, 2026

Feb 26, 2026

Keros Therapeutics (KROS) CEO awarded 317,000 stock options with vesting hurdles - Stock Titan

Feb 26, 2026

Feb 26, 2026

Keros Therapeutics (KROS) CFO receives 60,000-share stock option grant - Stock Titan

Feb 26, 2026

Feb 26, 2026

Keros Therapeutics (KROS) awards Chief Legal Officer 80,000 options - Stock Titan

Feb 26, 2026

Feb 26, 2026

Keros Therapeutics (NASDAQ: KROS) grants CSO 75,000 options - Stock Titan

Feb 26, 2026

Feb 26, 2026

Ex-Lyell CFO and healthcare banker Charles Newton joins Keros board - Stock Titan

Feb 26, 2026

Feb 25, 2026

KROS Technical Analysis & ETF Price Forecast - Intellectia AI

Feb 25, 2026

Feb 21, 2026

Keros Therapeutics, Inc. (KROS) Investor Outlook: Analyzing a 38.97% Potential Upside in the Biotech Sector - DirectorsTalk Interviews

Feb 21, 2026

Feb 20, 2026

Keros Therapeutics (KROS) CEO auto-sells 7,015 shares for tax withholding - Stock Titan

Feb 20, 2026

Feb 20, 2026

Can Keros Therapeutics Inc. reach resistance levels soonJuly 2025 Outlook & Verified Swing Trading Watchlists - mfd.ru

Feb 20, 2026

Feb 19, 2026

Risk Hedge: What is the next catalyst for Keros Therapeutics IncQuarterly Portfolio Report & Long-Term Safe Investment Ideas - baoquankhu1.vn

Feb 19, 2026

Feb 19, 2026

Portfolio Update: Is now the right time to enter Keros Therapeutics IncJuly 2025 Movers & Low Risk Growth Stock Ideas - baoquankhu1.vn

Feb 19, 2026

Feb 19, 2026

Keros Therapeutics CEO to Present at Multiple Conferences - The Globe and Mail

Feb 19, 2026

Feb 18, 2026

Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences - The Manila Times

Feb 18, 2026

Feb 18, 2026

Keros Therapeutics CEO to Present at Oppenheimer, TD Cowen and Leerink Conferences - TradingView

Feb 18, 2026

Feb 18, 2026

Keros Therapeutics (NASDAQ: KROS) lines up CEO talks at key conferences - Stock Titan

Feb 18, 2026

Feb 18, 2026

Sentiment Recap: Can Keros Therapeutics Inc weather a recessionQuarterly Trade Review & Weekly Stock Performance Updates - baoquankhu1.vn

Feb 18, 2026

Feb 18, 2026

Should Investors Buy, Sell or Hold KROS Stock Ahead of Q4 Earnings? - TradingView

Feb 18, 2026

Feb 18, 2026

Keros Therapeutics (KROS) Projected to Post Quarterly Earnings on Wednesday - MarketBeat

Feb 18, 2026

Feb 17, 2026

Tang Capital reports 0% stake in Keros Therapeutics (NASDAQ: KROS) - Stock Titan

Feb 17, 2026

Feb 17, 2026

D. E. Shaw group discloses 3.9% Keros Therapeutics (KROS) ownership in 13G/A - Stock Titan

Feb 17, 2026

Feb 16, 2026

Keros Therapeutics, Inc. (NASDAQ:KROS) Given Consensus Recommendation of "Hold" by Analysts - MarketBeat

Feb 16, 2026

Feb 14, 2026

Will Keros Therapeutics Inc. stock keep outperforming rivalsQuarterly Market Review & Community Verified Trade Alerts - mfd.ru

Feb 14, 2026

Feb 14, 2026

Can Keros Therapeutics Inc. reach all time highs this yearJuly 2025 Analyst Calls & Safe Capital Growth Stock Tips - mfd.ru

Feb 14, 2026

Feb 13, 2026

Keros Therapeutics, Inc. (KROS) Stock Analysis: Spotlight on a 37.72% Potential Upside in Biotech - DirectorsTalk Interviews

Feb 13, 2026

Feb 11, 2026

Is Keros Therapeutics Inc. likely to announce a buybackMarket Performance Summary & Free Fast Entry Momentum Trade Alerts - mfd.ru

Feb 11, 2026

Feb 11, 2026

Why Keros Therapeutics Inc. stock could see breakout soon2025 Market Sentiment & Smart Allocation Stock Tips - mfd.ru

Feb 11, 2026

Feb 11, 2026

What analyst consensus says on Keros Therapeutics Inc. stockQuarterly Growth Report & Safe Entry Momentum Tips - mfd.ru

Feb 11, 2026

Feb 11, 2026

How much upside does Keros Therapeutics Inc. haveWeekly Trading Summary & Real-Time Buy Signal Alerts - mfd.ru

Feb 11, 2026

Feb 07, 2026

Keros Therapeutics: Key Catalysts and Financial Runway in Focus - AD HOC NEWS

Feb 07, 2026

Feb 06, 2026

Price-Driven Insight from (KROS) for Rule-Based Strategy - Stock Traders Daily

Feb 06, 2026

Feb 06, 2026

How Keros Therapeutics Inc. stock benefits from global expansion2025 Fundamental Recap & Reliable Entry Point Trade Alerts - mfd.ru

Feb 06, 2026

Feb 03, 2026

Y Intercept Hong Kong Ltd Lowers Holdings in Keros Therapeutics, Inc. $KROS - MarketBeat

Feb 03, 2026

Feb 02, 2026

Keros Therapeutics, Inc. $KROS Shares Sold by Federated Hermes Inc. - MarketBeat

Feb 02, 2026

Feb 01, 2026

Big Picture: What is SIDUs revenue forecastGap Up & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn

Feb 01, 2026

Jan 30, 2026

Risk Report: What is the next catalyst for Keros Therapeutics IncDividend Hike & High Accuracy Trade Alerts - baoquankhu1.vn

Jan 30, 2026

Jan 29, 2026

Tech Rally: Is CleanCore Solutions Incs ROE strong enough2025 Stock Rankings & Risk Managed Trade Strategies - baoquankhu1.vn

Jan 29, 2026

Jan 29, 2026

Aug Opening: Will HUB Cyber Security Ltd. Equity Warrant outperform during market ralliesJuly 2025 WrapUp & Target Return Focused Stock Picks - baoquankhu1.vn

Jan 29, 2026

Jan 27, 2026

Keros Therapeutics vs. Dyne: Which DMD Biotech Has More Upside? - Nasdaq

Jan 27, 2026

Jan 26, 2026

Portfolio Shifts: Can NECB benefit from deglobalizationJuly 2025 Reactions & Community Driven Trade Alerts - baoquankhu1.vn

Jan 26, 2026

Jan 26, 2026

Market Wrap: What is the next catalyst for Keros Therapeutics IncAnalyst Downgrade & Capital Efficiency Focused Ideas - baoquankhu1.vn

Jan 26, 2026

Jan 26, 2026

Is KROS' KER-065 the Next Breakthrough in DMD Space? - The Globe and Mail

Jan 26, 2026